As described above, macrophages can be subtyped in M1 (MHCIIhigh, MRC−) or M2 (MHCIIlow,MRC+) of which the latter are known to reduce inflammation and negatively affect the prognosis in GBM. This evidence concerns the gene CD200 and glioblastoma.